Phathom Pharmaceuticals, Inc.
NASDAQ:PHAT
4.11 (USD) • At close April 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 297.263 | 381.393 | 155.385 | 183.259 | 287.496 | 243.765 | 0.879 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 297.263 | 381.393 | 155.385 | 183.259 | 287.496 | 243.765 | 0.879 |
| Net Receivables
| 38.797 | 1.637 | 0 | 0 | 0.082 | 0 | 0 |
| Inventory
| 3.208 | 1.208 | 0 | 0 | -0.082 | 0 | 0 |
| Other Current Assets
| 20.866 | 13.194 | 10.254 | 6.534 | 7.744 | 23.672 | 0.004 |
| Total Current Assets
| 360.134 | 397.432 | 160.512 | 186.526 | 291.368 | 255.601 | 0.902 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 2.089 | 3.621 | 3.494 | 2.564 | 3.359 | 1.396 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0.505 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 16.095 | 12.789 | 0.299 | 0.341 | 0.384 | 0.181 | 0 |
| Total Non-Current Assets
| 18.184 | 16.41 | 4.298 | 2.905 | 3.743 | 1.577 | 0 |
| Total Assets
| 378.318 | 413.842 | 164.81 | 189.431 | 295.111 | 257.178 | 0.902 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 10.507 | 12.601 | 9.997 | 5.15 | 16.782 | 0.699 | 0.055 |
| Short Term Debt
| 1.002 | 0.726 | 1.416 | 0.974 | 8.301 | 0.322 | 1.95 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 2.475 | -1.95 |
| Other Current Liabilities
| 74.219 | 25.454 | 14.824 | 12.797 | 30.441 | 2.727 | 0.183 |
| Total Current Liabilities
| 85.728 | 38.781 | 26.237 | 18.921 | 55.524 | 3.748 | 2.188 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0 | 138.304 | 96.362 | 90.854 | 41.191 | 23.412 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 546.17 | 309.516 | 117.025 | 7.5 | 4.125 | 2.063 | 0 |
| Total Non-Current Liabilities
| 546.17 | 447.82 | 213.387 | 98.354 | 45.316 | 25.475 | 0 |
| Total Liabilities
| 631.898 | 486.601 | 239.624 | 117.275 | 100.84 | 29.223 | 2.188 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.006 | 0.005 | 0.003 | 0.003 | 0.003 | 0.002 | 0 |
| Retained Earnings
| -1,263.011 | -928.685 | -727.093 | -529.37 | -385.487 | -256.419 | -1.288 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 1,009.425 | 855.921 | 652.276 | 601.523 | 579.755 | 484.372 | 0.002 |
| Total Shareholders Equity
| -253.58 | -72.759 | -74.814 | 72.156 | 194.271 | 227.955 | -1.286 |
| Total Equity
| -253.58 | -72.759 | -74.814 | 72.156 | 194.271 | 227.955 | -1.286 |
| Total Liabilities & Shareholders Equity
| 378.318 | 413.842 | 164.81 | 189.431 | 295.111 | 257.178 | 0.902 |